INTRODUCTION {#S1}
============

The development of the mammalian foetus is completely dependent on support from the extra-embryonic tissues, which provide the connection with the mother and are important signalling centres for patterning the early post-implantation embryo. The founder lineages for both the foetus and the extra-embryonic tissues arise sequentially from the totipotent blastomeres in the morula and early blastocyst. By the time of implantation, the blastocyst consists of three lineages: the extra-embryonic trophectoderm (TE) and primitive endoderm (PrE); and the epiblast, which develops into the foetus. The correct segregation of these three populations is therefore crucial, and failure to do so causes embryonic lethality. The formation of the TE has been studied extensively (reviewed by [@R4]; [@R48]); however, the mechanisms regulating the segregation of the PrE and the pluripotent epiblast are only starting to be understood.

Epiblast and PrE are formed in a multi-step process from the inner cell mass (ICM) of the blastocyst (reviewed by [@R45]). In a first phase, epiblast and PrE precursors are specified in the naïve ICM of the early blastocyst (∼32 cells). At this stage, all ICM cells express the epiblast markers *Nanog* and *Sox2*, and the early PrE markers *Gata6* and *Pdgfra* ([@R3]; [@R20]; [@R38]). Several lines of evidence indicate FGF signalling is necessary for the specification of PrE cells ([@R1]; [@R12]; [@R16]; [@R24]; [@R35]; [@R53]). Fgf4, which is produced by epiblast precursors, is thought to induce PrE fate among the rest of ICM cells ([@R13]; [@R18]; [@R20]). Next, cell identity is reinforced, likely through sustained FGF signalling, leading to the exclusive expression of *Nanog* and *Gata6*/*Pdgfra* in epiblast and PrE precursors, which appear scattered in a 'salt and pepper' fashion in the mid blastocyst (∼64 cells) ([@R3]; [@R38]). PrE cells at this stage start to express GATA4 ([@R26]; [@R38]). Finally, from mid to late blastocyst (100-120 cells), these two lineages segregate into two separate compartments: PrE precursors migrate until they reach the surface of the ICM and become exposed to the blastocyst cavity, where they remain to eventually form a mature epithelium, leaving the epiblast enclosed between PrE and TE ([@R38]). It has therefore been proposed that positional information is instrumental for the spatial segregation of PrE and epiblast ([@R15]; [@R38]; [@R40]; [@R42]). However, to date, no molecular players that translate positional information into the resolution of the 'salt and pepper' pattern have been identified. Furthermore, whether a relationship exists between the segregation of PrE and epiblast cells and lineage maturation has not been addressed.

Mature PrE cells become polarised, with receptors such as LRP2, or the endocytic adaptor DAB2, on their apical membrane ([@R15]; [@R55]) and the ability of PrE cells to become polarised has been proposed to be important for the sorting out of the PrE and epiblast ([@R31]; [@R43]). The atypical protein kinase C proteins (aPKCs) are involved in establishing apicobasal polarity and determining cell fate across metazoa ([@R51]). aPKCs are the most abundant of the PKC isoforms in the mouse pre-implantation embryo ([@R36]) and play a central role in the polarisation of outer cells of the morula, which induces TE fate ([@R6]; [@R10]; [@R23]; [@R37]; [@R40]). We therefore sought to determine whether aPKC is involved in relaying positional signals that mediate the resolution of the 'salt and pepper' pattern and promote PrE maturation.

In this work, we present aPKC as a central player during the segregation of PrE and epiblast, where it couples cell sorting with lineage progression in PrE cells. We show that aPKC is enriched in prospective PrE cells prior to the sorting of the PrE and epiblast populations and prior to overt signs of cell polarisation. Subsequently, aPKC adopts a polarised localisation in PrE cells, only after they reach the blastocyst cavity and form a mature epithelium, in a process dependent on FGF signalling. We found that aPKC is necessary for PrE cell sorting and survival, and for its organisation as an epithelial layer. Moreover, inhibition of aPKC activity from the mid blastocyst stage not only prevents the sorting of PrE precursors into a polarised monolayer but concomitantly affects the maturation of PrE precursors. We propose a mechanism whereby aPKC translates positional information to resolve the 'salt and pepper' pattern by promoting both maturation of PrE and sorting of PrE and epiblast cells into separate layers.

MATERIALS AND METHODS {#S2}
=====================

Embryo collection and culture {#S3}
-----------------------------

The mice used belonged to the CD1 strain, or the transgenic lines *Pdgfra^H2B-GFP/+^* ([@R22]), *CAG::GFP-GPI* ([@R41]) or *CAG::H2B-EGFP* ([@R21]). Animals were maintained under a 12-hour light/dark cycle in the designated facilities of the University of Manchester, UK. Embryos from natural matings were collected and handled in M2 medium ([@R17]) supplemented with 4 mg/ml BSA (Sigma) and staged as described previously ([@R38]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S1A). Mouse handling and husbandry followed the regulations established in the UK Home Office's Animals (Scientific Procedures) Act 1986.

Embryos were cultured in microdrops of KSOM-AA medium ([@R17]; [@R27]) under mineral oil (Sigma) at 37.5°C in a 5% CO~2~ atmosphere. The zona pellucida was always removed from embryos cultured from the early/mid blastocyst onwards by briefly washing in acidic Tyrode's solution (Sigma).

Inhibitors {#S4}
----------

All PKC inhibitors were purchased from Calbiochem ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Table S2)~.~ Increasing concentrations of the inhibitors were assayed ([Table 2](#T2){ref-type="table"}) and sublethal concentrations used to assess their effect on PrE organisation. The aPKC inhibitor Gö6983 was added to the culture medium at 5 μM for most experiments (Tables [1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). However, we observed batch-to-batch variation in the potency of the inhibitor; therefore, concentrations ranging from 5 (Lot\# D00140253) to 10 μM (Lot\# D00120125) were used in a set of experiments.

FGF signalling modulation {#S5}
-------------------------

ERK1/2 and GSK3 inhibitors (2i) \[PD0325901 (1 μM) and Chir99021 (3 μM), respectively ([@R35])\] were a kind gift from Jenny Nichols (Cambridge Stem Cell Institute, Cambridge, UK). Recombinant human FGF4 (rhFGF4, R&D Systems) was diluted at 500 ng/ml in KSOM-AA in the presence of 1 μg/ml of heparin (Sigma) as described previously ([@R53]).

RNAi {#S6}
----

Double-stranded RNA (dsRNA) molecules were synthesised using the MEGAscript RNAi Kit (Ambion) following the manufacturer's instructions. Template DNAs (∼400 bp) were amplified by PCR from CDSs cloned into plasmid vectors. Templates to produce dsRNA against mCherry and GFP (dsCherry and dsGFP) were amplified using the following primers: 5′-TAATACGACTCACTATAGGGAGACCGACTACTTGAAGCTGTCCTT-3′ and 5′-TAATACGACTCACTATAGGGAGAGTTCCACGATGGTGTAGTCCTC-3′ for dsCherry; and 5′-TAATACGACTCACTATAGGGAGAAGCTGACCCTGAAGTTCATCTG-3′ and 5′-TAATACGACTCACTATAGGGAGAGATCTTGAAGTTCACCTTGATGC-3′ for dsGFP. Templates for dsRNA against *Prkci* (PKCλ) and *Prkcz* (PKCλ) were amplified using the following primers: 5′-TAATACGACTCACTATAGGGAGAGACAAGTCCATTTACCGGAGAG-3′ and 5′-TAATACGACTCACTATAGGGAGACGAAATCCTGCAGACCTAGACT-3′ for PKCλ; and 5′-TAATACGACTCACTATAGGGAGATTTCTTCATCTCGGAAACATGA-3′ and 5′-TAATACGACTCACTATAGGGAGAGAAGTTTTCTCTGCCTCTGCAT-3′ for PKCζ.

All dsRNAs were diluted in nuclease-free water for injection. dsPKCs were injected at 250 or 500 ng/μl (for each isoform) in different experiments and dsCherry was injected at 500 ng or 1 μg/μl, respectively. The results with either concentration of dsPKCλ+ζ and dsCherry were equivalent, and therefore data from both concentrations were pooled together.

Synthetic mRNA preparation {#S7}
--------------------------

All capped mRNAs were transcribed *in vitro* using the mMESSAGE mMachine kit (Ambion) following the manufacturer's recommendations. mRNAs were diluted in nuclease-free water and injected at 1 μg/μl.

Embryo microinjection {#S8}
---------------------

Single-blastomere injections were performed on glass depression slides (Fisher) on an inverted Leica DMI 6000B microscope equipped with DIC optics, Leica micromanipulators and an Eppendorf FemtoJet injector unit, essentially as described previously ([@R34]) (see also [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S2A).

Immunofluorescence {#S9}
------------------

Embryos were fixed and immunofluorescence performed as described ([@R38]). Details on the primary antibodies used are provided in [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Table S1. All secondary antibodies were AlexaFluor (Invitrogen), diluted 1:500 and were applied for 60-75 minutes. Nuclei were stained with 5 μg/ml Hoechst 33342 (Sigma) in PBS.

Image acquisition {#S10}
-----------------

Four-dimensional (4D) imaging was performed in a Nikon A1R inverted confocal microscope equipped with an Okolab incubation chamber and a motorised stage for multi-point simultaneous imaging. Optical sections (2-3 μm) were taken every 15 minutes through whole embryos in order to build 3D *z*-stacks. Control and experimental embryos were imaged in parallel in each experiment and fixed at the end of the imaging period. *Z*-stacks of embryos injected with dsRNA were obtained at 24 hours post-injection (hpi) and subsequently fixed at 48 hpi. Fixed embryos were mounted in drops of ProLong Gold antifade reagent (Invitrogen) or directly in Hoechst solution on glass-bottom dishes (MatTek). Optical sections through fixed whole embryos were taken every 1-2 μm using an Olympus FluoView FV1000 inverted confocal microscope, a Nikon A1R or a Zeiss LSM 510 Meta.

Image analysis {#S11}
--------------

Nuclei were manually counted using ImageJ (NIH) or Imaris (Bitplane). Movies were compiled from 4D sequences using Imaris. Immunofluorescence was quantified along linear regions of interest (ROIs) using ImageJ. Linear ROIs minimise the bias when determining the limits of the region to be analysed (cell borders, in the absence of a membrane marker, and the breadth of the apical side), provide a large enough dataset and allow for a graphical representation of the protein distribution. ROIs were drawn across mid-sections of either single cells or groups of cells from the same lineage ([Fig. 1B-D′](#F1){ref-type="fig"}) or along the apical or basolateral surfaces of cells lining the ICM surface ([Fig. 1D′,G](#F1){ref-type="fig"}). Grayscale values for each ROI were averaged to obtain the mean intensity for each population and stage. At least four embryos were analysed per stage, with ROIs defined in three medial optical sections per ICM. Measurements were taken within the same or adjacent sections in order to avoid differences in intensity due to loss of signal along the *z* axis.

Embryos injected with dsRNA were analysed using ImageJ (NIH) and Imaris (Bitplane). Cell borders were marked by membrane-anchored GFP-GPI in *CAG::GFP-GPI* embryos ([@R41]), which was used to score the position of labelled (H2B-GFP+) cells (inside or outside) at 24 hours on 3D stacks (see [Fig. 3A](#F3){ref-type="fig"}).

Cell position was also scored on fixed embryos. Cells on the periphery of the blastocyst were scored as TE. We observed that the H2B-GFP signal often became too weak to be detected after fixation and immunofluorescence, making cell counting and scoring position challenging. In embryos injected with dsPKCλ+ζ, often a reduction in aPKC levels was evident, regardless of the presence of H2B-GFP (see [Fig. 3G,H](#F3){ref-type="fig"}). In these cases, those cells were considered part of the injected clone. Whenever aPKC levels were simply lower than in neighbouring cells, or the difference was unclear, only the presence of H2B-GFP was used to determine the injected clone. In embryos injected with dsCherry, only the presence of H2B-GFP could be used to determine the progeny of injected cells, as aPKC levels were unaffected ([Fig. 3F](#F3){ref-type="fig"}). Cells were scored as being on the ICM surface when one of their surfaces was exposed to the blastocyst cavity and as internal when completely surrounded by their neighbours. The presence or absence of GATA4 was scored for cells positioned either on the surface or the inside of the ICM.

Because of the different contribution to the ICM by control and experimental embryos in dsRNA experiments, the number of labelled cells in the ICM were normalised against the total number of labelled ICM cells for each embryo.

Statistical analysis {#S12}
--------------------

Statistical analyses were performed using Graphpad Prism. Statistical tests were performed as indicated in the text and figure legends. When applying the χ^2^ test to analyse the effect of different inhibitors on PrE sorting, due to the low *n* values for some conditions, data for different concentrations of each inhibitor were pooled because there were no apparent differences between them ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S4B; [Table 2](#T2){ref-type="table"}).

RESULTS {#S13}
=======

aPKC is enriched in primitive endoderm precursors {#S14}
-------------------------------------------------

The mature PrE in the peri-implantation blastocyst (E4.5) is an epithelium separating the epiblast from the blastocyst cavity ([@R9]; [@R15]; [@R49]). The localisation and role of the polarity protein aPKC have been well studied in the TE, the first extra-embryonic epithelium to form in the mouse ([@R6]; [@R36]; [@R37]), but not in the PrE. We therefore performed an immunolocalisation assay at consecutive stages of pre-implantation development in order to define the localisation pattern of aPKC in the PrE.

Up to the early blastocyst, aPKC presents high nuclear levels and localises to the cell contacts and the apical surface of outer cells, as previously described ([@R36]; [@R37]; [@R40]) ([Fig. 1A](#F1){ref-type="fig"}). In the ICM of the early blastocyst, it is found throughout both cytoplasm and nuclei, as well as on cell contacts ([Fig. 1A,E](#F1){ref-type="fig"}). In mid and late blastocysts (≈64-130 cells), aPKC levels are heterogeneous between individual ICM cells ([Fig. 1A-C](#F1){ref-type="fig"} and [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 1, 2), with a distribution that resembles the 'salt and pepper' pattern of PrE and epiblast precursors ([@R3]) and suggesting aPKC could be marking one of these two populations. To examine this possibility, we co-stained embryos for aPKC and GATA4, a marker for PrE cells. GATA4 is found exclusively in PrE cells from the mid blastocyst onwards ([@R26]; [@R38]). High levels of aPKC are always found in cells positive for GATA4. Fluorescence intensity profiles through mid-sections of PrE (GATA4+) and epiblast (GATA4-) precursors revealed that PrE precursors in mid and late blastocysts are significantly enriched in aPKC compared with epiblast ([Fig. 1B,C](#F1){ref-type="fig"}, charts; *P*\<0.0001, *n*=15 sections in five embryos for mid blastocysts, *n*=18 sections in six embryos for late blastocysts). Cells negative for GATA4 were positive for NANOG ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S1C), as previously shown ([@R26]; [@R38]).

![**aPKC is enriched in PrE precursors from the mid blastocyst.** (**A**) Immunofluorescence for aPKC at successive stages of pre-implantation development. (**B-D**′) Quantification of aPKC levels from mid- to E4.5 blastocysts. Red lines/bars indicate PrE precursors (GATA4+); blue lines/bars indicate epiblast precursors (GATA4-). (**D**′) Quantification of aPKC levels along apical (grey/white) and basal (black) membranes of the PrE at E4.5. Histograms compare fluorescence intensity between both ROIs on the ICM depicted. Bar charts compare averages from several measurements. Dashed lines on histograms represent averages for profiles shown. (**E**) Immunofluorescence for aPKC and E-cadherin on an early-mid blastocyst showing aPKC localisation on the membrane/cortex. (**F**) Immunofluorescence for aPKC and E-cadherin at E4.5. There is a low aPKC staining throughout the ICM, except on the apical membrane of PrE cells. (**G**) Colocalisation of aPKC and DAB2 at E4.5. Histogram shows overlay of aPKC and DAB2 levels on the pictures above. ^\*\*^*P*\<0.01, ^\*\*\*^*P*\<0.001, unpaired Student's *t*-test. Bar charts display mean+s.e.m. *n*, number of embryos. Scale bars: 20 μm.](DEV093922F1){#F1}

In E4.5 blastocysts, where all PrE cells are sorted into an epithelium on the ICM surface, aPKC localises to the apical membrane of PrE cells, presenting low cytoplasmic levels, equivalent to those of epiblast cells ([Fig. 1D,D′,F,G](#F1){ref-type="fig"}). aPKC colocalises with other polarised components of the PrE, such as DAB2 ([@R15]) ([Fig. 1G](#F1){ref-type="fig"}), although it seems to begin to polarise prior to DAB2 ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S1D).

In summary, the distribution of aPKC in the ICM of the mouse blastocyst displays distinct phases that correlate with phases of PrE specification. Initially homogeneous levels of aPKC in the ICM of the early blastocyst become heterogeneous as embryos progress towards the mid blastocyst stage. aPKC thus becomes enriched in PrE precursors concomitantly with the establishment of the 'salt and pepper' pattern of PrE and epiblast precursors, prior to cell sorting. Finally, aPKC polarises in the mature, committed PrE epithelium. This correlation between the enrichment of aPKC and the specification of PrE precursors raises the issue of whether these processes are connected.

aPKC enrichment is specific to the primitive endoderm and depends on FGF/ERK signalling {#S15}
---------------------------------------------------------------------------------------

To address whether the heterogeneity in aPKC levels throughout the ICM was a consequence of the acquisition of PrE fate, we prevented PrE specification by blocking ERK activity ([@R35]; [@R53]) and then assessed aPKC localisation.

We applied ERK1/2 and GSK3 inhibitors (2i) to embryos from the eight-cell stage to prevent PrE specification ([Fig. 2A](#F2){ref-type="fig"}). Embryos cultured in the presence of 2i do not have PrE cells (marked by GATA4), as described ([Fig. 2B,F](#F2){ref-type="fig"}) ([@R35]). After 48 hours of culture in 2i (late blastocysts), embryos present homogeneous, low levels of aPKC throughout the ICM ([Fig. 2F](#F2){ref-type="fig"}), whereas control embryos display significantly higher levels of aPKC in PrE cells, like late blastocysts ([Fig. 2E](#F2){ref-type="fig"}, [Fig. 1C](#F1){ref-type="fig"}; data not shown). After 72 hours in culture, control embryos have a polarised PrE (20/20 embryos, at least eight polarised cells), equivalent to E4.5 blastocysts ([Fig. 2C,G,H](#F2){ref-type="fig"}; [Fig. 1D](#F1){ref-type="fig"}). However, most embryos (23/26) treated with 2i present few (less than eight cells) or no polarised cells in the ICM ([Fig. 2C,H](#F2){ref-type="fig"}).

![**aPKC enrichment and polarisation are downstream of FGF/ERK signalling.** (**A**) Schematic of 2i or Fgf4 treatment. (**B**) Number of GATA4 cells in control and 2i conditions. (**C**) Number of polarised cells on the ICM surface per embryo. 20/20 control embryos had at least eight cells. 23/26 2i-treated embryos had 0-6 polarised cells. (**D**) Number of GATA4 cells in control and Fgf4-treated embryos. (**E-H**) Immunofluorescence for aPKC and GATA4 in the ICM. (E) Higher levels of aPKC in PrE cells of control embryos after 48 hours (arrows), but not in those treated with 2i (F). (G) Polarised apical aPKC in PrE cells in controls after 72 hours (arrowheads), but not in 2i-treated embryos (H). (**I-M**) Immunofluorescence as in E-H for Fgf4 treatment. Both control (I,K) and experimental (J,L,M) embryos have apical aPKC in cells on the ICM surface (arrowheads). All data are collected from three replicas of each experiment. ^\*\*^*P*\<0.01, ^\*\*\*^*P*\<0.001, unpaired Student's *t*-test. Bar charts display mean+s.e.m. *n*, number of embryos. Scale bars: 20 μm.](DEV093922F2){#F2}

We then cultured embryos in saturating doses of FGF4, which induce PrE fate throughout the ICM ([@R53]). Embryos treated with 500 ng/ml of Fgf4 for 48 hours ([Fig. 2A](#F2){ref-type="fig"}) express GATA4 throughout the ICM, and begin to show apically polarised aPKC in cells on the ICM surface, like control embryos cultured in parallel ([Fig. 2D,I,J](#F2){ref-type="fig"}, arrowheads) (mean=16.4 GATA4+ cells, *n*=21 embryos in controls; mean=28.33 GATA4+ cells, *n*=6 in Fgf4-treated embryos). Interestingly, longer culture periods in Fgf4 (72 hours) do not result in a further expansion of the PrE when compared with controls, which also have an epiblast (mean=31.6 GATA4+ cells, *n*=21 embryos in controls; mean=32.5 GATA4+ cells, *n*=20 in Fgf4-treated embryos) ([Fig. 2D](#F2){ref-type="fig"}). These data suggest FGF signalling is involved in the specification of the PrE, but is not sufficient for its proliferation. In embryos exposed to Fgf4 for 72 hours, although the entire ICM expresses GATA4, only ICM cells in contact with the cavity present aPKC on the apical membrane ([Fig. 2K-M](#F2){ref-type="fig"}, arrowheads), indicating aPKC polarisation in PrE cells is dependent on cell position. Of note, however, in the majority of these embryos, the ICM becomes a monolayer, spread underneath the polar TE, with no epiblast ([Fig. 2M](#F2){ref-type="fig"}). In these embryos, all ICM cells are polarised, indicating that aPKC polarisation is a hallmark of PrE epithelialisation.

These data show the heterogeneous levels of aPKC and its subsequent polarisation depend on the acquisition of PrE identity downstream of FGF signalling. Our results show the ability to develop an apical domain is inherent to PrE cells and dependent on both FGF/ERK signalling and cell positioning within the ICM. This ability may be essential for PrE organisation, as previously proposed ([@R31]; [@R43]).

Knockdown of aPKC prevents PrE cells from reaching the ICM surface {#S16}
------------------------------------------------------------------

We have shown aPKC is specifically enriched in PrE precursors prior to cell sorting. To address the role of aPKC in PrE formation, we performed mosaic knockdown using double-stranded RNA (dsRNA)-mediated RNA interference (RNAi). dsRNA is highly efficient and specific for gene knockdown in pre-implantation embryos ([@R52]). In order to avoid defects in TE development as the result of aPKC knockdown in the whole embryo ([@R6]; [@R37]), we targeted one single blastomere at the eight-cell stage, causing a mosaic knockdown ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S2A). As a technical control, we injected dsRNA against GFP (dsGFP), which was able to knock down efficiently GFP in *CAG::H2B-GFP; CAG::GFP-GPI* embryos ([@R21]; [@R41]) ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S2B).

Mouse pre-implantation embryos express both aPKC isoforms, PKCλ and PKCζ ([@R36]). Therefore, we synthesised dsRNA molecules targeting both isoforms (dsPKCλ and dsPKCζ; see Materials and methods) that were co-injected with mRNA for H2B-GFP as a tracer. Control embryos were injected with dsRNA targeting mCherry. Consistently with previous reports, PKCλ+ζ knockdown causes an increased contribution to the ICM by the targeted cells compared to control embryos ([Fig. 3A-C](#F3){ref-type="fig"}) ([@R6]; [@R37]). No difference was found in the total number of labelled cells between controls and experimental embryos ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S2D,E). Furthermore, immunofluorescence at 24 hours post-injection (hpi) showed a marked reduction in cytoplasmic levels of aPKC ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S2C). Notably, nuclear aPKC is largely unaffected by the dsRNAs, suggesting this protein pool may be of maternal origin.

![**Knockdown of aPKC prevents PrE cells from reaching the ICM surface.** (**A**) Live images 24 hours post-injection (hpi). Arrowheads indicate cells on the ICM surface in control embryo. Dashed line indicates inner cells in experimental embryo. (**B**) Percentage of labelled ICM cells (H2B-GFP+) per embryo at 24 hpi. (**C**) Percentage of labelled ICM cells per embryo at 48 hpi. (**D**) Percentage of labelled PrE cells (GATA4+) per embryo at 48 hpi. (**E**) Percentage of labelled PrE cells (GATA4+) on the ICM surface per sorted embryo at 48 hpi. (**F-H**) Immunofluorescence for aPKC and GATA4 in representative embryos. Arrowheads indicate labelled GATA4+ cells. Asterisks indicate labelled GATA4-cells inside the ICM. Insets show the detail of ICMs. Each channel also overlaid with nuclear staining in all panels. ^\*\*^*P*\<0.01; ^\*\*\*^*P*\<0.001, unpaired Student's *t*-test (B,C) or Mann-Whitney U-test (D,E). Charts display mean+s.e.m. In scatter dot plot, each dot represents one embryo. *n*, number of embryos. Scale bars: 20 μm.](DEV093922F3){#F3}

Embryos fixed at 48 hpi also display significantly more labelled cells in the ICM than control embryos ([Fig. 3C](#F3){ref-type="fig"}). Therefore, for any further analysis of labelled ICM cells, numbers were normalised against the total number of labelled ICM cells for each embryo (in percent) (see Materials and methods for details). aPKC knockdown reduces the contribution to the PrE by the progeny of the injected cells, albeit not statistically significant (58.2% of GATA4+ labelled ICM cells for dsCherry, 43.2% for dsPKCs, *P*=0.2526 in Mann-Whitney U-test, [Fig. 3D,F,G](#F3){ref-type="fig"}). However, in embryos injected with dsPKCs, there is a significant reduction in the proportion of labelled PrE cells (H2B-GFP+ and/or aPKC-, GATA4+) found on the ICM surface. All the labelled PrE cells were located on the ICM surface in control embryos, whereas only 72.4% of them were on the surface when aPKC was knocked down (*P*\<0.01 in Mann-Whitney U-test) ([Fig. 3E,F,H](#F3){ref-type="fig"}). In both cases, all non-labelled PrE cells in the embryos analysed were on the ICM surface.

Our data therefore show that in the absence of aPKC, PrE precursors fail to sort successfully, indicating aPKC may be necessary for the segregation of PrE and epiblast precursors.

Inhibition of aPKC in mid blastocysts impairs the segregation of PrE and epiblast {#S17}
---------------------------------------------------------------------------------

Our RNAi knockdown shows a defect in the sorting of PrE precursors in the absence of aPKC. However, it allows the analysis of only a subpopulation of cells. Therefore, we used an inhibitor to disturb aPKC throughout the embryo. This approach also allows temporal control of the treatment, so we applied the inhibitor to blastocysts over the time when the PrE and epiblast populations segregate ([Fig. 4A](#F4){ref-type="fig"}).

![**Inhibition of aPKC in mid blastocysts impairs the segregation of PrE and epiblast.** (**A**) Schematic of PKC inhibitor treatment. (**B**) Snapshots of a control embryo cultured in 1% DMSO. (**C**,**D**) Snapshots of two embryos cultured in 5 μM Gö6983. See [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 4-6, respectively. Green fluorescence indicates H2B-GFP expressed from the *Pdgfra* locus (PrE precursors). (**E**) Percentage of sorted embryos: 89% of embryos have a sorted PrE layer after 1% DMSO treatment, 37% of embryos have a sorted PrE layer after 5 μM Gö6983 treatment (*P*\<0.0001, Fisher's exact test; see [Table 1](#T1){ref-type="table"}). (**F**) Time course of PrE expansion. Each line represents one embryo (number of GFP+ cells over time). Bold lines correspond to embryos in B-D as indicated (asterisks). (**G**) Number of apoptoses per cell division. (**H**) PrE (GFP+) expansion from the beginning to the end of the culture. ^\*\*^*P*\<0.01, unpaired Student's *t*-test. Bar charts display mean+s.e.m. Scale bars: 20 μm.](DEV093922F4){#F4}

We used the bisindolylmaleimide Gö6983 to inhibit aPKC. Bisindolylmaleimides are staurosporine derivatives with a higher specificity for PKCs over other kinases ([@R19]). This inhibitor has been used previously to show that aPKC is involved in TE formation ([@R10]) and can maintain ES cells in an undifferentiated state in the absence of LIF, through the inhibition of PKCζ ([@R8]), suggesting it may prevent ICM differentiation. As a control for the activity of the inhibitor, we treated embryos with Gö6983 from the eight-cell stage up to the blastocyst stage. Treated morulas initiate cavitation but fail to expand the cavity and to maintain TE integrity ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S4A,B), consistent with the described role of aPKC in TE formation ([@R6]; [@R11]).

To gain more insight into the effect of blocking aPKC during PrE formation, we treated embryos with 5 μM of Gö6983 from the mid- to the late blastocyst, the period when PrE and epiblast precursors become segregated ([Fig. 4A](#F4){ref-type="fig"}). We imaged this process using embryos that harbour a knock-in H2B-GFP fusion at the *Pdgfra* locus (*Pdgfra*^H2B-GFP^), a bona fide reporter for *Pdgfra* expression, which is a PrE marker ([@R22]; [@R38]). Moreover, the presence of H2B-GFP in PrE cells allows visualisation of cell migration, cell division and cell death.

Live imaging of control embryos revealed PrE cells migrate throughout the ICM until they reach the surface, where they remain to form a layer between the epiblast and the blastocyst cavity ([Fig. 4B](#F4){ref-type="fig"} and [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movie 4), as previously described ([@R38]). However, in embryos treated with aPKC inhibitor, PrE precursors fail to remain on the ICM surface ([Fig. 4B-D](#F4){ref-type="fig"}). They migrate through the ICM, but cannot maintain their position when they come into contact with the cavity. Instead, they often migrate deeper into the ICM, where they remain scattered or die by apoptosis ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 5, 6). While 88.7% of control embryos (47/53) presented a sorted PrE layer at the end of the experiment, only 37% (20/54) of embryos treated with Gö6983 did ([Fig. 4E](#F4){ref-type="fig"}; [Table 1](#T1){ref-type="table"}), a difference that was highly significant (*P*\<0.0001).

###### 

**Embryo survival and PrE sorting**

![](table001)

We then followed the growth of the PrE population, scoring cell divisions and cell deaths in a subset of embryos ([Fig. 4F](#F4){ref-type="fig"}). aPKC inhibition does not prevent cell division ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 5, 6); however, there is an increase in the apoptosis:cell-division ratio that affects the expansion of the PrE ([Fig. 4G](#F4){ref-type="fig"}). On average, we found a twofold increase in the size of the PrE compartment in control embryos, but no significant expansion in experimental embryos ([Fig. 4H](#F4){ref-type="fig"}).

Given that Gö6983 also targets other PKC isoforms besides aPKC ([@R8]; [@R19]) (see [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Table S2), we repeated our assay with a panel of commercial broad-range PKC inhibitors targeting all other PKC isoforms affected by Gö6983, except aPKC, to control for its specificity ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Table S2). Neither of these inhibitors, even the structurally related bisindolylmaleimide Gö6976, caused a phenotype like that observed for Gö6983 ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S3A,B; [Table 2](#T2){ref-type="table"}). Embryos developed normally in the presence of any of these inhibitors and presented a sorted PrE, with no apparent reduction in the number of GATA4+ cells ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S3A; [Table 2](#T2){ref-type="table"}). These results, in combination with our RNAi data, strongly indicate the phenotype observed is specifically the result of aPKC inhibition.

###### 

**Screen for PKC inhibitors**

![](table002)

Our results therefore show that aPKC inhibition affects the behaviour of PrE precursors, which fail to organise as a layer on the ICM surface and display increased apoptosis. Interestingly, they do not seem to undergo a switch in cell fate, as they do when treated with FGF/ERK inhibitors, as they maintain *Pdgfra* expression (reported by H2B-GFP) ([Fig. 4B-D](#F4){ref-type="fig"}), indicating that aPKC and FGF signalling have distinct effects on PrE identity.

Inhibition of aPKC prevents the maturation of PrE identity {#S18}
----------------------------------------------------------

We have shown that knockdown or inhibition of aPKC cause a defect in PrE sorting. However, the live reporter used allows visualisation of only PrE cells and changes in *Pdgfra* expression. To gain more insight into the state of ICM lineages upon aPKC inhibition, we analysed the expression of epiblast and PrE lineage markers in fixed samples.

Our live imaging data revealed a defect in the expansion of the PrE when embryos were treated with Gö6983, but did not show whether this was the result of a general increase in cell death throughout the embryo. OCT4 staining distinguishes ICM (OCT4+) from TE cells (OCT4-, in the periphery of the blastocyst). When combined with staining for GATA4 - the first exclusive marker of the PrE - it allows quantification of all three lineages in the blastocyst (PrE cells: OCT4+, GATA4+; epiblast cells: OCT4+, GATA4-) (see [Fig. 5A′](#F5){ref-type="fig"} and [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movie 7). We found no difference in the number of TE cells between control and experimental embryos ([Fig. 5C](#F5){ref-type="fig"}), indicating aPKC inhibition does not affect the growth of the TE after this lineage has been established. However, treatment with Gö6983 causes a significant reduction in the number of ICM cells ([Fig. 5C,D](#F5){ref-type="fig"}), which is entirely due to the observed reduction in the number of GATA4+ cells ([Fig. 5D](#F5){ref-type="fig"}; [Fig. 4H](#F4){ref-type="fig"}). By contrast, when embryos were allowed to develop in culture until an overt PrE layer was apparent on the ICM surface and then cultured for further 24 hours in the presence of the inhibitor ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S4C), no defect was observed in the PrE. Embryos grown in these conditions presented equivalent numbers of PrE cells as control embryos ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S4D; *n*=11 embryos for control group, *n*=8 for Gö6983). Moreover, they retained a monolayer of GATA4+ cells ([supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Fig. S4E,F), indicating that, as observed for the TE, aPKC activity is necessary for the establishment of the PrE epithelium, but not for maintaining the integrity of the mature tissue.

![**Inhibition of aPKC prevents the maturation of PrE identity.** (**A-B**′) Late blastocysts, live (A,B) and stained for GATAA4 and OCT4 after culture in 1% DMSO (A′) or 5 μM Gö6983 (B′). GATA4 is present beyond the nuclear borders after treatment with Gö6983. See also [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 7-9. (**C**) Total, TE and ICM cell numbers. *n*=17 embryos for 1% DMSO, *n*=13 for 5 μM Gö6983. (**D**) Cell numbers for each ICM lineage. *n*=41 embryos for 1% DMSO, *n*=36 for 5 μM Gö6983. (**E-H**) Immunofluorescence for aPKC, DAB2 and GATA4 (E,F) or LRP2 and GATA4 (G,H). Insets show detail of ICMs. Each channel also overlaid with nuclear staining in all panels. ^\*\*\*^*P*\<0.001, unpaired Student's *t*-test. Bar charts display mean±s.e.m. Scale bars: 20 μm.](DEV093922F5){#F5}

In addition, we found that embryos that cannot form a PrE layer concomitantly fail to develop a polarised apical surface. Control embryos display an apical domain of aPKC, LRP2 and DAB2 in PrE cells on the ICM surface, as described previously ([@R15]) (this report) (8/10 embryos for aPKC, 2/3 for DAB2, 3/5 for LRP2; [Fig. 5E,G](#F5){ref-type="fig"}). However, most embryos treated with the inhibitor lack a polarised PrE (10/18 embryos for aPKC, 3/3 for DAB2, 11/13 for LRP2; [Fig. 5F,H](#F5){ref-type="fig"}).

Both in control and experimental embryos, PrE cells maintain or upregulate *Pdgfra*^H2B-GFP^ expression ([Fig. 4B-D](#F4){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movies 4-6), suggesting that aPKC inhibition does not cause a switch in cell fate. To test this hypothesis, we assessed the distribution of the epiblast marker NANOG and the PrE marker GATA4. We found the domains of NANOG and GATA4 expression do not overlap, in either control (8/8 embryos) or experimental embryos (8/8 embryos) ([Fig. 6A,B](#F6){ref-type="fig"}), indicating there is no upregulation of epiblast markers in PrE precursors upon aPKC inhibition. However, unlike control embryos, where all ICM cells are either NANOG+ or GATA4+ (7/8 embryos), all experimental embryos present between 1 and 3 double-negative cells ([Fig. 6B](#F6){ref-type="fig"}, asterisks). These cells presumably express OCT4, as OCT4 is present in all ICM cells in equivalent assays, but they could not be assigned to either the epiblast or PrE lineage. Unexpectedly, GATA4 is often found in the cytoplasm upon aPKC inhibition (25/41 embryos, compared with 0/41 in controls) and occasionally completely excluded from the nucleus ([Fig. 5B′](#F5){ref-type="fig"}; [Fig. 6E,F](#F6){ref-type="fig"}; [supplementary material](http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.093922/-/DC1) Movie 8). However, we also found what seemed to be accumulations of the inhibitor in bright red speckles, making it hard to distinguish them from protein staining. These observations suggest aPKC inhibition may cause a loss of nuclear GATA4 in a proportion of PrE cells, which could account for the presence of NANOG-, GATA4-cells.

![**Inhibition of aPKC prevents the maturation of PrE identity.** (**A**,**B**) Immunofluorescence for GATA4 and NANOG in representative embryos after culture in 1% DMSO or 5 μM Gö6983. Asterisks indicate double-negative cells, with no staining for either NANOG or GATA4. (**C**,**D**) Immunofluorescence for GATA6 and NANOG as in A,B. Arrow indicates a NANOG+, GATA6+ cell on the ICM surface after Gö6983 treatment. (**E**) Immunofluorescence for GATA4 and OCT4 after treatment with 5 μM Gö6983. GATA4 is excluded from the nuclei present in the cytoplasm throughout the ICM. (**F**) Immunofluorescence for GATA4 and NANOG after treatment with 5 μM Gö6983. GATA4 is distributed throughout the cell marked with arrows (nucleus and cytoplasm). (**G**) Immunofluorescence for GATA4 and GATA6 after treatment with 10 μM Gö6983. Arrowheads indicate polar TE cells that retain GATA6 (normally found only in PrE and mural TE at this stage).](DEV093922F6){#F6}

In order to test whether aPKC inhibition also affected the expression of earlier PrE markers, we stained embryos for NANOG and the early PrE marker GATA6. Unlike for GATA4, in these embryos we could never find double-negative cells (12/12 embryos treated with Gö6983, [Fig. 6D](#F6){ref-type="fig"}), suggesting the NANOG-, GATA4-cells observed retain GATA6. Of note, GATA6 was never found to display cytoplasmic staining. Interestingly, although in control embryos the domains of NANOG and GATA6 never overlap (4/4 embryos) ([Fig. 6C](#F6){ref-type="fig"}), 5/12 embryos treated with aPKC inhibitor displayed NANOG+, GATA6+ cells in the ICM ([Fig. 6D](#F6){ref-type="fig"}, arrows). This result suggests inhibition of aPKC affects PrE maturation concomitant with its segregation and survival. To address this possibility, we double stained for GATA6 and GATA4. In all control embryos, GATA6 and GATA4 colocalise in PrE cells (3/3 embryos); however, we found that in 3/11 embryos treated with Gö6983, the domain of GATA6 expression was much broader than that of GATA4 ([Fig. 6G](#F6){ref-type="fig"}).

These results indicate that, although aPKC inhibition does not cause a switch in cell fate from PrE to epiblast, it compromises the maturation of PrE cells. Moreover, the failure to segregate PrE and epiblast cells suggests the maturation of PrE cells could be linked to their organisation as a monolayer at the ICM surface. Interestingly, GATA4 has been previously proposed to be necessary for the correct spatial organisation of endoderm cells ([@R2]). This correlation suggests GATA4 might provide a link between cell sorting and lineage maturation in PrE cells.

DISCUSSION {#S19}
==========

In the ICM of the mammalian blastocyst, a stochastic gene expression pattern is gradually stabilised through paracrine stimulation of the FGF/ERK pathway to produce an ICM composed of intermingled PrE and epiblast precursors ([@R3]; [@R13]; [@R24]; [@R35]; [@R53]). These two populations become separated into two compartments through active cell migration, anchoring of PrE cells at the ICM surface and elimination of mispositioned PrE cells ([@R29]; [@R38]; [@R53]). Although it has been proposed that polarisation of PrE cells may be important in this process ([@R15]; [@R31]; [@R43]), the molecular mechanisms driving it remain unknown. Here, we describe aPKC as a central player orchestrating the transition from the 'salt and pepper' distribution of PrE and epiblast cells into two separate mature lineages.

The distribution of aPKC in the ICM presents phases that correlate with phases of gene expression and changes in localisation of PrE cells, suggesting an involvement of aPKC in these processes. A specific increase in aPKC accompanies the specification of PrE cells and is maintained during PrE and epiblast segregation. aPKC only becomes polarised upon the establishment of the PrE as an epithelial monolayer, in the peri-implantation blastocyst (E4.5). Interestingly, it is at this stage that PrE and epiblast cells have been shown to be completely committed to their respective fates ([@R14]; [@R18]), indicating overt polarisation of aPKC is a hallmark of epithelialisation in the PrE and correlates with cell fate stabilisation.

We found that modulation of the FGF/ERK signalling pathway changes the levels and distribution of aPKC within the ICM. Our results not only show that aPKC is specifically enriched in PrE cells, but also that epiblast cells are unable to form an epithelium, even when engaged in asymmetrical cell contacts. The genetic programme triggered in PrE cells is thus very different from that of epiblast cells and directs the formation of a stereotypical, polarised epithelium with a basement membrane separating it from the epiblast ([@R9]; [@R15]; [@R32]; [@R49]; [@R54]). It does so partly in a cell-autonomous manner, as embryos treated with FGF4 lack an epiblast, but display a monolayer of polarised PrE cells. However, the epiblast may be necessary for proliferation of this tissue, because embryos grown with FGF4 have equivalent numbers of PrE cells to control embryos, which have an epiblast.

Importantly, we have shown that either knockdown or chemical inhibition of aPKC cause a defect in PrE sorting, as well as a marked increase in cell death among PrE cells. Apoptosis within the ICM has been previously described ([@R5]; [@R38]) and it has been postulated as a mechanism to eliminate PrE cells mispositioned deep within the ICM ([@R38]). Here, we show that when aPKC activity is blocked, PrE cells do not undergo cell fate switch - because they maintain the expression of early PrE markers - but do undergo apoptosis regardless of their location, suggesting they are unable to perceive positional cues, and therefore behave as mispositioned PrE cells.

Our results show that aPKC promotes survival and stabilises the position of PrE cells that reach the ICM surface before it becomes polarised. This suggests aPKC can affect cell fate independently of its role as a polarity protein. aPKC is known to regulate cell survival and apoptosis through the interaction with an array of signalling partners ([@R7]; [@R28]) (reviewed by [@R33]; [@R39]; [@R46]). Moreover, the role of nuclear aPKC described in other systems ([@R44]) suggests nuclear aPKC in the blastocyst may be important in this process. The promiscuity of aPKC in its target selection and its ability to activate other transcription factors ([@R46]; [@R47]) makes it possible for it to directly or indirectly regulate GATA4 localisation in PrE cells. Although this possibility certainly requires more detailed investigation, our immunofluorescence data for GATA4 in conditions of aPKC inhibition suggest this could be the case. By contrast, we have not encountered cytoplasmic GATA4 when using RNAi, suggesting this could be either a non-specific effect of the inhibitor or the result of aPKC inhibition throughout the embryo instead of clonal downregulation. We show here that aPKC inhibition affects the maturation of PrE cells; in these conditions, cells can be found in the ICM that express OCT4 and GATA6, but not GATA4 (or NANOG), indicating that although these cells have adopted a PrE fate, they fail to progress further. Frankenberg and colleagues have shown that in the absence of NANOG and RTK stimulation, GATA6+ cells show increased cell death ([@R13]). We speculate that in the absence of aPKC activity, cells that downregulate NANOG and maintain GATA6, but fail to activate GATA4, may also undergo cell death. This possibility could account for the low numbers of GATA6+, GATA4-cells found. The fact that *Gata4*^-/-^ embryos survive until mid-gestation ([@R25]; [@R30]) does not support this view; however, *in vitro* experiments using ES cells point in the same direction we propose ([@R2]; [@R50]). Further details on the interaction between GATA6, GATA4 and other players ([@R2]) will be necessary before we can address this issue.

We therefore propose a model where aPKC couples the resolution of the 'salt and pepper' pattern of PrE and epiblast cells with the maturation of the PrE ([Fig. 7](#F7){ref-type="fig"}). In this model, after an initial step of PrE specification mediated by FGF4, aPKC directs the sorting of PrE and epiblast cells into two distinct compartments, concomitantly with the maturation of lineage identities. Exposure of PrE cells to the blastocyst cavity would trigger survival signals in these cells, allowing the formation of a polarised epithelial layer and lineage commitment. Thus, our data imply that the sorting of PrE and epiblast cells represents the second major step in PrE formation, necessary for the transition from a primed to a mature state and where aPKC plays a pivotal role connecting cell sorting with progression of cell differentiation.

![**Proposed model for PrE formation.** ICM cells become primed towards a PrE or epiblast fate through the action of paracrine Fgf4. Sustained production of Fgf4 by epiblast precursors reinforces PrE fate, which is accompanied by aPKC enrichment in PrE precursors and upregulation of GATA4. aPKC would trigger survival signals in PrE cells that reach the ICM surface, which maintain their position. aPKC becomes polarised on the apical side of PrE cells at E4.5, when the PrE forms an epithelium.](DEV093922F7){#F7}
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